Real-World Safety and Efficacy of Nivolumab in Advanced Squamous and Nonsquamous Non-Small-Cell Lung Cancer: A Retrospective Cohort Study in Croatia, Hungary, and Malta

BACKGROUND: There is a lack of real-world data on the safety and efficacy of nivolumab in patients with previously treated advanced non-small-cell lung cancer (NSCLC) especially in South East Europe, a region with particularly high incidence and an unfavorable mortality-to-incidence ratio for lung c...

Descripción completa

Detalles Bibliográficos
Autores principales: Vrdoljak, Eduard, Jakopović, Marko, Geczi, Lajos, Bogos, Krisztina, Bošković, Lidija, Magri, Claude, Bitar, Lela, Bajić, Žarko, Samaržija, Miroslav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738788/
https://www.ncbi.nlm.nih.gov/pubmed/33376489
http://dx.doi.org/10.1155/2020/9246758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738788/
https://www.ncbi.nlm.nih.gov/pubmed/33376489
http://dx.doi.org/10.1155/2020/9246758

Ejemplares similares